Aggregate Spend

AGGREGATE SPEND SOFTWARE WHITE PAPERS AND CASE STUDIES

AGGREGATE SPEND PRODUCTS

Opto Diode provides an extensive selection of high-power LEDs, available in both standard and customizable configurations, tailored to meet the demanding requirements of the Space, Aerospace, Military, and Defense sectors.

The devices ImageMaster HR and Universal provide an outstanding level of accuracy and flexibility when testing the MTF (modulation transfer function).

The AMP4065-LCP1 solid state high power amplifier operates within a wide frequency range of 18.0 - 26.5 GHz with a power output exceeding 60 Watts in CW mode and a minimum of 40 Watts (typical: 50 Watts) at P1dB.

The Pulsa Series hydraulic diaphragm metering pumps was the foundation upon which Pulsafeeder was built. For over 70 years Pulsa Series hydraulic pumps have been synonymous with dependability, quality and precision engineering, and are still depended upon to provide years, even decades, of year round operation. Available with a variety of diaphragm styles to deliver everything from thin fluids to lime slurries, materials of construction for contact with the most hazardous chemicals and features and options to provide safe, remote and accurate dosing, count on Pulsa Series for the most demanding applications.

The Future of Precision Medicine: Radiopharmaceutical Preparation for Targeted Diagnostics and Treatment

Safer and More Effective Radiopharmaceutical Production With Germfree's Advanced Cleanrooms and Equipment Solutions

Radiopharmaceuticals are drugs that contain radioactive isotopes and are used as diagnostic and therapeutic agents. Due to the hazardous nature of radioisotopes, lead shielded aseptic processing equipment is required for their production and handling. These cleanrooms have specific requirements such as HEPA exhaust and biosecurity features to prevent contamination and protect workers.

Germfree’s expertise in designing facilities and equipment for complex critical environments ensures compliant radiopharmaceutical preparation and production at varying scales. Radiopharmaceuticals play a crucial role in advanced therapies, including nuclear medicine and cancer treatment, and are a rapidly growing sector of the biopharmaceutical industry.

Delivering on the promise of cell and gene therapy

Germfree is a leader in creating mobile and modular facilities specifically for cell and gene therapy (CGT) manufacturing. As CGT sits at the crossroads of medical research and pharmaceutical development, it demands highly specialized cleanroom designs. These designs must focus on efficient workflows, strict separation procedures, and rigorous aseptic processing to ensure the best results. Despite the quick growth and logistical challenges in the CGT field, Germfree’s mobile solutions effectively tackle these issues. They enable distributed manufacturing, ease the collection of patient cells, and help make CGT treatments accessible globally.

AqueoUS Vets is a multidisciplinary firm that focuses on standard and customized water treatment systems. We offer a superior line of products for pumping, conveyance, filtration, and storage for dewatering projects.

Explore new capabilities extend finished optics wavelength range from mid-UV to longwave infrared.

AGGREGATE SPEND SOFTWARE NEWS

ABOUT

Aggregate Spend

Aggregate Spend refers to the process used to aggregate and monitor the total amount spent on organizations and individual healthcare professionals by healthcare manufacturers. The amount spent is aggregated in terms of payments made, honoraria, gifts, travel and other means. Aggregate spend is also known as the Physician Spend Sunshine Law which is an initiative that is aimed to achieve transparency in life sciences industry, the benefits of each physician as well as to limit spend per physician. The law is a body of state and federal legislations. Passing of this law was also in effort to alleviate the conflicts of interest between pharmaceutical and medical device companies and healthcare professionals.

The process requires that manufactures of various medical devices, drugs, biological and other supplies recorded all payments made to physicians including any other transfers of value to teaching hospitals and physicians. Report regarding all this information is required to be produced annually by all the applicable manufacturers and suppliers. The manufacturers are required to include details such as date, nature of payment and the value. Penalties are charged in case of breaching this law by the target parties.

By doing this, accountability of individual physicians and medical device, pharmaceutical and life sciences companies can be achieved. The challenge now is to the life science companies to address the reporting requirements and more so now that state and federal regulatory agency continue to enact legislation that require more auditing of monetary transactions to physicians and organizations involved in healthcare management. As a result many companies are now working more diligently to address compliance and gain more competitive advantage through reputation management among other ways.